American Society of Clinical Oncology recommendations on fertility preservation in cancer patients.
By Stephanie J. Lee, L. Schover, A. Partridge, P. Patrizio, W. Hamish B. Wallace, K. Hagerty, L. Beck, L. Brennan, K. Oktay. Journal of Clinical Oncology, 2006
1,955 citations recorded by the source corpus.
Subfields: Public Health, Environmental and Occupational Health, Reproductive Medicine
View Paper: https://www.semanticscholar.org/paper/24af743457719ad2cbb514871c16df52e46430e7
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Public Health, Environmental and Occupational Health
In Reproductive Medicine
Citations in the corpus
- Mature oocyte cryopreservation: a guideline. (2013, background): “The gonadotoxicity of chemotherapeutics and radiotherapy has been well documented (42).”
- Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2015, background): “In younger premenopausal patients, possible fertility issues should be discussed and guidance about fertility-preservation techniques provided before initiation of treatment [31, 32].”
- Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. (2019, background): “ver 100,000 individuals less patients to reproductive specialists’’ (2).”
- Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. (2013, background): “(1) With recent data supporting longer duration of hormonal therapies for estrogen receptor/progesterone receptor–positive breast cancer, larger numbers of women will be affected by the risk of compromised fertility.”
- Consensus Statement on the Use of Gonadotropin-Releasing Hormone Analogs in Children (2009, neutral): “patients have yielded inconsistent results(102-104).”